LU87176A1 - Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments - Google Patents

Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments Download PDF

Info

Publication number
LU87176A1
LU87176A1 LU87176A LU87176A LU87176A1 LU 87176 A1 LU87176 A1 LU 87176A1 LU 87176 A LU87176 A LU 87176A LU 87176 A LU87176 A LU 87176A LU 87176 A1 LU87176 A1 LU 87176A1
Authority
LU
Luxembourg
Prior art keywords
tolyl
signifies
compound
formula
tert
Prior art date
Application number
LU87176A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87176A1 publication Critical patent/LU87176A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
LU87176A 1987-04-01 1988-03-23 Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments LU87176A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3411887A 1987-04-01 1987-04-01
US3411887 1987-04-01

Publications (1)

Publication Number Publication Date
LU87176A1 true LU87176A1 (fr) 1988-11-17

Family

ID=21874422

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87176A LU87176A1 (fr) 1987-04-01 1988-03-23 Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments

Country Status (18)

Country Link
JP (1) JPS63277672A (hu)
KR (1) KR880012224A (hu)
AU (1) AU1400788A (hu)
BE (1) BE1000783A3 (hu)
DE (1) DE3810874A1 (hu)
DK (1) DK179288A (hu)
ES (1) ES2011831A6 (hu)
FR (1) FR2613226B1 (hu)
GB (1) GB2202849A (hu)
GR (1) GR880100196A (hu)
HU (1) HUT50156A (hu)
IL (1) IL85920A0 (hu)
IT (1) IT1219895B (hu)
LU (1) LU87176A1 (hu)
NL (1) NL8800805A (hu)
PT (1) PT87127B (hu)
SE (1) SE8801166L (hu)
ZA (1) ZA882350B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701961D0 (en) * 1987-01-29 1987-03-04 Unilever Plc Perfumery materials

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3235589A1 (de) * 1982-09-25 1984-03-29 Hoechst Ag, 6230 Frankfurt Benzylether von phenol-mannich-basen, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK179288D0 (da) 1988-03-30
GR880100196A (el) 1989-01-31
IL85920A0 (en) 1988-09-30
DK179288A (da) 1988-10-02
GB2202849A (en) 1988-10-05
GB8807503D0 (en) 1988-05-05
BE1000783A3 (fr) 1989-04-04
NL8800805A (nl) 1988-11-01
SE8801166L (sv) 1988-10-02
AU1400788A (en) 1988-10-06
FR2613226A1 (fr) 1988-10-07
ZA882350B (en) 1989-12-27
IT1219895B (it) 1990-05-24
IT8847797A0 (it) 1988-03-30
HUT50156A (en) 1989-12-28
PT87127B (pt) 1992-07-31
PT87127A (pt) 1988-04-01
SE8801166D0 (sv) 1988-03-29
DE3810874A1 (de) 1988-10-20
JPS63277672A (ja) 1988-11-15
FR2613226B1 (fr) 1989-09-15
KR880012224A (ko) 1988-11-26
ES2011831A6 (es) 1990-02-16

Similar Documents

Publication Publication Date Title
FR2612516A1 (fr) Derives de benzoxazole et preparation les contenant
JPH06507151A (ja) 抗アテローム硬化性アリール化合物
EP1401432B1 (fr) Derives d'imidazoles modulant les canaux sodiques
CA2055859A1 (fr) Derives d'oxazolopyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2498188A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
CH642635A5 (fr) Derives de l'imidazole, procedes pour leur preparation et compositions medicamenteuses contenant ces derives.
LU86002A1 (fr) Composes d'aminophenol
EP0623138B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
EP0109866A1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
WO1993015100A1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
BE1003632A3 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments.
LU87176A1 (fr) Derives du 1,3-dioxolanne et du 1,3-dioxanne et leur utilisation comme medicaments
EP0143016B1 (fr) Dérivés de 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phényl acétamide, leur préparation et leur application en thérapeutique
EP1001942B1 (fr) Polyhydroxybutylpyrazines, leur preparation et medicaments les contenant
CH661271A5 (fr) Derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant.
CH630909A5 (en) New 3,5-disubstituted-1H-1,2,4-triazoles
JPS60158149A (ja) 炎症抑制作用を有する１，４‐ナフトキノン誘導体
EP0179076B1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
FR2605006A1 (fr) Derives du 5-fluorouracile, procede pour leur preparation, composition anticancereuse les contenant et leur utilisation pour la preparation d'une composition destinee au traitement d'un cancer
WO1995029154A1 (fr) Nouveaux derives de benzylamines, leur procede de fabrication et les compositions pharmaceutiques les renfermant
EP0424214A1 (fr) Dérivés de 5-[2-[[2-amino-2-oxoéthyl]méthylamino]éthyl]-2,3-dihydro-3-hydroxy-2-(4-méthoxy-phényl)-1,5(5H)-benzothiazépine-4-one, leur préparation et leur application en thérapeutique
FR2578839A1 (fr) Composes allyliques polysubstitues, procede pour leur fabrication et compositions contenant ces composes utilisables comme medicament
EP0275221A2 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
LU81895A1 (fr) Nouveaux derives de la perhydrothiazine-1,3, leur preparattion et les medicaments qui les contiennent
FR2523129A1 (fr) Derives de 3-azetidinylethyl-1-phenyl-2-imidazolidinone, medicaments les contenant et procede pour leur preparation